Characteristics and outcomes of patients with relapsed follicular lymphoma following retreatment with second-line rituximab-containing chemotherapy.

Jiajia Liu,Douglas A. Stewart,Amelie Fontaine,Anthea C. Peters,Isabelle Fleury,Luigina Mollica,Anca Prica,Rena Buckstein,Laurie H. Sehn,Aixiang Jiang,John Kuruvilla,Diego Villa

Characteristics and outcomes of patients with relapsed follicular lymphoma following retreatment with second-line rituximab-containing chemotherapy.

2020

Jiajia Liu
Douglas A. Stewart
Amelie Fontaine
Anthea C. Peters
Isabelle Fleury
Luigina Mollica
Anca Prica
Rena Buckstein
Laurie H. Sehn
Aixiang Jiang
John Kuruvilla
Diego Villa

The prognosis of patients with follicular lymphoma (FL) with high tumor burden or advanced stage disease treated with upfront immunochemotherapy is relatively favorable with 10-year overall surviva...

Keywords:

Oncology
Follicular lymphoma
Diabetes mellitus
Rituximab
Immunology
second line
Medicine
Internal medicine
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations